HCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow HCA
HCA Healthcare, Inc. (HCA) EV/EBITDA
As of 16 October 2026, HCA Healthcare, Inc. (HCA) trades at a EV/EBITDA of 9.4×. Over the past ten years it has ranged from 5.7× (March 2020) to 11.2× (March 2026); the current reading is higher than 87% of that period. That is below the Medical Care Facilities industry median of 10.2× and in line with the Healthcare sector median of 9.2×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 10.0× | 17.02% |
| FY2024 | 8.5× | (4.22%) |
| FY2023 | 8.9× | (0.05%) |
| FY2022 | 8.9× | (2.82%) |
| FY2021 | 9.2× | 8.81% |
| FY2020 | 8.4× | (0.25%) |
| FY2019 | 8.4× | 0.44% |
| FY2018 | 8.4× | 7.35% |
| FY2017 | 7.8× | 9.06% |
| FY2016 | 7.2× | (1.10%) |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Jun 2026 | 8.5× | (12.88%) |
| Mar 2026 | 9.8× | (2.31%) |
| Dec 2025 | 10.0× | 6.31% |
| Sep 2025 | 9.4× | 1.45% |
| 42 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 4.9× |
| UHS Universal Health Services, Inc. compare | 5.8× |
| THC Tenet Healthcare Corporation compare | 6.1× |
| DVA DaVita Inc. compare | 7.8× |
| HCA HCA Healthcare, Inc. | 9.4× |
| EHC Encompass Health Corporation compare | 10.3× |
| PACS PACS Group, Inc. compare | 15.6× |
| CHE Chemed Corporation compare | 16.5× |
| ENSG The Ensign Group, Inc. compare | 17.2× |
| Medical Care Facilities industry median | 10.2× |
| Healthcare sector median | 9.2× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on HCA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement